Factors Associated with Improved HIV/AIDS Treatment Outcomes: Comparing two Major ART Service Delivery Models in Vietnam

AIDS Behav. 2019 Oct;23(10):2840-2848. doi: 10.1007/s10461-019-02571-z.

Abstract

A mixed design approach was performed to assess the CD4 count levels over time and their associated factors among 362 HIV patients on ART from clinics with HIV testing and counseling (ART-HTC) services and those with general healthcare (ART-GH) services. Longitudinal CD4 count data were retrospectively collected from medical records. Sociodemographic, clinical, alcohol use and smoking characteristics were obtained via face-to-face interviews. Multivariate mixed effect linear regression was utilized to determine the association. We found that HIV patients at ART-GH clinics were more likely to achieve higher CD4 counts over time compared to patients at ART-HTC clinics. Additionally, having an increase in CD4 counts was found to be associated with having longer duration of ART and higher baseline CD4 levels. Cigarette smoking and hazardous alcohol use, however, were not associated with CD4 count improvement. Our findings suggest that combining HTC and GH services might provide a synergistic benefit in ART treatment outcomes through an improved access to comprehensive HIV healthcare services for HIV patients on therapy.

Keywords: ART service delivery models; Alcohol use; Cigarette smoking; HIV testing and counseling services; HIV treatment outcome.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Alcohol Drinking / epidemiology
  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • Counseling
  • Cross-Sectional Studies
  • Delivery of Health Care, Integrated / methods*
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology
  • HIV Infections / virology
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Primary Health Care / organization & administration*
  • Retrospective Studies
  • Smoking / epidemiology
  • Treatment Outcome
  • Vietnam / epidemiology

Substances

  • Anti-HIV Agents